Automated Staining Aids Real-Time Tumor Calls - Report - MDSpire

Automated Staining Aids Real-Time Tumor Calls

Automated frozen-section staining helped classify selected ambiguous tumors and margins in a single-center validation study.

  • By

  • Andrea Surnit

  • May 11, 2026

  • 3 min

Share

Clinical Report: Automated Staining Aids Real-Time Tumor Calls

Overview

A rapid automated immunohistochemistry (FFRA-IHC) approach significantly improved tumor classification in intraoperative settings, resolving ambiguous cases in 68% of previously unclassifiable tumors. This method also clarified all ambiguous resection margins, potentially impacting surgical decision-making.

Background

Intraoperative pathology relies heavily on frozen-section hematoxylin and eosin staining, which can sometimes yield ambiguous results. The introduction of rapid automated immunohistochemistry (FFRA-IHC) may enhance diagnostic accuracy and expedite decision-making during surgery. This study highlights the potential of FFRA-IHC to supplement traditional methods in challenging cases.

Data Highlights

{'format': 'Ensure the table is visually clear and accessible.'}

Key Findings

  • FFRA-IHC classified 68% of previously unclassifiable tumors.
  • All ambiguous resection margins were resolved using FFRA-IHC.
  • The antibody panel included CK-AE, CK5, CK7, CD45, and synaptophysin.
  • FFRA-IHC potentially altered intraoperative management in approximately 12% of cases.
  • Turnaround time for FFRA-IHC averaged 21 minutes, with total diagnosis time around 40 minutes.

Clinical Implications

The implementation of FFRA-IHC in intraoperative settings may enhance diagnostic accuracy and expedite surgical decision-making. Clinicians should consider integrating this technology into routine practice, particularly in cases where traditional methods yield ambiguous results.

Conclusion

FFRA-IHC presents a promising adjunct to conventional frozen-section analysis, with the potential to significantly impact intraoperative management and patient outcomes. Further studies are warranted to evaluate its broader applicability and clinical significance.

References

  1. Journal of Pathology, Microbiology and Immunology, 2024 -- Automated Staining Aids Real-Time Tumor Calls
  2. the pathologist — Virtual Staining in the Tumor Microenvironment
  3. The ASCO Post — ASCO20 Virtual Scientific Program: Next-Generation Oncology Highlights
  4. Nature Medicine — An agentic framework for autonomous scientific discovery in cancer pathology
  5. The ASCO Post — New Assays, Surveillance Techniques Reported for GI Malignancies
  6. Virtual Staining in the Tumor Microenvironment
  7. ASCO20 Virtual Scientific Program: Next-Generation Oncology Highlights
  8. An agentic framework for autonomous scientific discovery in cancer pathology
  9. New Assays, Surveillance Techniques Reported for GI Malignancies
  10. Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update - PubMed
  11. Rapid Automated Immunohistochemistry on Frozen Sections Enables Real-Time Surgical Pathology Decisions - The Capital Region of Denmark's Research Portal

Original Source(s)

Automated Staining Aids Real-Time Tumor Calls

  • by Andrea Surnit

  • May 11, 2026

Related Content

Tzield Approval Expands to Younger Patients

First disease-modifying option available for children as young as 1 year with stage 2 type 1 diabetes

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.

Nodular Fasciitis May Mimic Sarcoma

Molecular testing may help avoid overtreatment when benign soft-tissue tumors present with atypical clinical or histologic features.